Publications by authors named "Xianghua Zhong"

Chronic wound infections, particularly multidrug-resistant microbe-caused infections, have imposed severe challenges in clinical administration. The therapeutic effectiveness of the current strategy using conventional antibiotics is extremely unsatisfactory. The development of novel treatment strategies to inhibit the infections caused by multidrug-resistant bacteria is highly desired.

View Article and Find Full Text PDF

Systemic infusion is a prevalent administration method for mesenchymal stromal cells (MSCs) in clinical trials. However, the inability to deliver a large number of therapeutic cells to diseased tissue is a substantial barrier. Here, we demonstrate that surface engineering of MSCs with polyvalent antibodies can effectively improve the targeting efficiency of MSCs to diseased tissue.

View Article and Find Full Text PDF

In this work, a smart nanoplatform responding to multiple biomarkers has been developed for the real-time tracking of the intracellular delivery of a 2D nanosystem. Our work provides a promising avenue for developing an optimized imaging nanoplatform for site-specific imaging and real-time tracking of the delivery process.

View Article and Find Full Text PDF

Klebsiella pneumoniae (K. pneumoniae) is a common bacterium whose drug-resistant can cause surgical failures and incurable infections in hospital patients. Thus, how to reverse or delay the resistance induction has become a great challenge for development antiresistant drug.

View Article and Find Full Text PDF

Bacterial infection, especially multidrug-resistant bacteria-induced infection, threatens human health seriously, which has posed great challenges for clinical therapy. The overuse of conventional antibiotics has given rise to bacterial resistance that severely restricts the clinical treatment options of conventional antibiotics. The development of highly effective antibacterial materials and therapeutic strategies to inhibit the multidrug-resistant bacteria-induced infections is of great urgency.

View Article and Find Full Text PDF

The ever-growing threats of multidrug-resistant bacterial infection and chronic wound healing have created an imperative need for the development of novel antibacterial materials and therapeutic strategies, especially for diabetic patients infected with multidrug-resistant bacteria. In this work, the nanocomplexes named as PB@PDA@Ag were used for eradicating multidrug-resistant bacteria and accelerating wound healing of MRSA-infected diabetic model with the assistance of laser irradiation. In vitro results revealed that the combinational strategy exerted a synergistic effect for anti-MRSA through disrupting cell integrity, producing ROS, declining ATP, and oxidizing GSH, comparing with PB@PDA@Ag or NIR laser irradiation alone.

View Article and Find Full Text PDF
Article Synopsis
  • Researchers developed a new nanocomposite, rGO@Ag@Dap, by combining reduced graphene oxide (rGO), silver nanoparticles (AgNPs), and Daptomycin to enhance stability and reduce antibiotic dosage.
  • In lab tests, these nanocomposites were effective against multiple pathogenic bacteria, particularly Gram-positive ones, by damaging cells and disrupting their metabolism.
  • Animal studies demonstrated that rGO@Ag@Dap not only killed bacteria on infected wounds but also aided in skin healing and collagen formation, suggesting a promising solution for antibiotic resistance issues.
View Article and Find Full Text PDF